Microcap Ledger Rocket One Inc. $RKTO
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Hoboken, NJ
- Fiscal year end
- December 31
- Shares outstanding
- 24,897,581 [10-Q 2026-08-14]
What the company doesAI summary of filing
Rocket One Inc. is a clinical-stage biopharmaceutical company developing therapies for unmet medical needs. The company's primary programs include HT-001, a topical formulation for treating dermatological side effects from cancer drugs, which is currently in Phase 2a clinical trials in the United States and Europe; HT-KIT, targeting mast cell-derived cancers and anaphylaxis, currently undergoing IND-enabling studies; and HT-ALZ, for Alzheimer's disease and neuroinflammatory diseases, in preclinical development. The company has generated no revenue from commercial sales and relies on licensing agreements with universities and government entities for its drug candidates. Hoth currently has 2 full-time employees, 3 employee consultants, and 1 part-time employee, and relies on third parties for manufacturing and clinical trial conduct. [10-K 2026-03-27]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | −$6.53M | −$6.02M | $7.89M | [10-Q 2026-08-14] |
| FY ended Dec 2025 | — | −$12.47M | −$9.80M | $6.25M | [10-K 2026-03-27] |
| FY ended Dec 2024 | — | −$8.19M | −$6.98M | $7.04M | [10-K 2026-03-27] |
- Quarterly cash burn
- −$3.01M
- Cash runway Estimate
- ~7.9 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-08 | 6,903,804 | [10-Q 2024-11-12] |
| 2025-03-28 | 13,170,715 | [10-K 2025-03-28] |
| 2025-05-09 | 13,208,915 | [10-Q 2025-05-12] |
| 2025-08-11 | 13,259,027 | [10-Q 2025-08-12] |
| 2025-11-11 | 15,514,312 | [10-Q 2025-11-12] |
| 2026-03-26 | 16,257,652 | [10-K 2026-03-27] |
| 2026-05-14 | 19,127,643 | [10-Q 2026-05-15] |
| 2026-08-14 | 24,897,581 | [10-Q 2026-08-14] |
- Shelf registration
- S-3 filed 2025-11-17; declared effective 2025-12-04 [S-3 2025-11-17]
Listing status
Current status: 4 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-08-11. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-08-11 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-08-11] |
| 2026-05-04 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-05-04] |
| 2025-05-16 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-05-16] |
| 2024-11-01 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-11-01] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-02 | PRE 14A | Proxy statement |
| 2026-09-25 | 8-K | Other events |
| 2026-09-22 | 8-K | Other events |
| 2026-08-14 | 10-Q | Quarterly report |
| 2026-08-11 | 8-K | Listing notice or transfer; Other events |
| 2026-07-31 | 8-K | Other events |
| 2026-07-31 | 424B5 | Prospectus or prospectus supplement |
| 2026-07-21 | 8-K | Other events |
| 2026-06-25 | 8-K | Other events |
| 2026-06-03 | 8-K | Other events |
| 2026-06-03 | 8-K | Other events |
| 2026-06-03 | 424B5 | Prospectus or prospectus supplement |
Alerts for $RKTO
Email me when Rocket One Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.